Crompton Greaves Intrinsic Value
Crompton Greaves (CROMPTON) median intrinsic value is ₹574.81 from 3 valuation models (range ₹530–₹577), vs current price ₹288.25 — +99.4% upside (Trading Below Calculated Value), margin of safety 49.9%. Browse CROMPTON annual financials for revenue, profit, balance sheet and cash flow data.
CROMPTON Valuation Methods Summary — DCF, Graham Number & P/E
Crompton Greaves intrinsic value across 3 models vs current price ₹288.25 — upside/downside and value range per method. Also explore CROMPTON price movement history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹574.81 | ₹517.33 - ₹632.29 | +99.4% | Book Value/Share: ₹229.92, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹576.50 | ₹518.85 - ₹634.15 | +100.0% | Revenue/Share: ₹712.87, P/S: 1.5x |
| Simple DCF (5Y) | dcf | ₹530.40 | ₹424.32 - ₹636.48 | +84.0% | CF Growth: 5.0%, Discount: 15% |
CROMPTON Intrinsic Value vs Market Price — All Valuation Models
Crompton Greaves fair value range ₹530–₹577 vs current market price ₹288.25 across 3 valuation models. For current market price and key ratios, visit Crompton Greaves share price chart.
CROMPTON Intrinsic Value Analysis — Undervalued or Overvalued?
Crompton Greaves median intrinsic value ₹574.81, current price ₹288.25 — Trading Below Calculated Value by 99.4%, margin of safety 49.9%.
What is the intrinsic value of CROMPTON?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Crompton Greaves (CROMPTON) is ₹574.81 (median value). With the current market price of ₹288.25, this represents a +99.4% variance from our estimated fair value.
The valuation range spans from ₹530.40 to ₹576.50, indicating ₹530.40 - ₹576.50.
Is CROMPTON undervalued or overvalued?
Based on our multi-method analysis, Crompton Greaves (CROMPTON) appears to be trading below calculated value by approximately 99.4%.
CROMPTON Financial Health — Key Ratios vs Industry Benchmarks
Crompton Greaves financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 10.37 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -71.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -20.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.51x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CROMPTON Cash Flow Quality — Operating & Free Cash Flow
Crompton Greaves operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹737 Cr | ₹672 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹843 Cr | ₹740 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹553 Cr | ₹553 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹736 Cr | ₹-132 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹830 Cr | ₹582 Cr | Positive Free Cash Flow | 8/10 |